Quarry Thera
The Future of Induced Proximity Therapeutics
United States · Founded 2023 · $32.0M raised
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- quarrythera.com
- Total Funding
- $32.0M
- Last Round
- $32.0M Series ANov 2025
- Rounds
- 1
About
Biotech developing next-generation molecular glue proximity-induced therapeutics; founded by ex-Pfizer CSO.
Summary
Quarry Thera is a Biotech company based in United States, founded in 2023. It has raised $32.0M in total across 1 round, most recently a $32.0M Series A round in Nov 2025. Investors include Yosemite, Canaan Partners and F-Prime Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/quarry-thera"><img src="https://indexed.vc/api/badge/company/quarry-thera" alt="Quarry Thera on Indexed.vc" width="260" height="76" /></a>